Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
Charlotte Syrykh, Sarah Péricart, Claire Lamaison, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3315-3315
Open Access | Times Cited: 22

Showing 22 citing articles:

Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers
Atharva S. Torne, Erle S. Robertson
Cancers (2024) Vol. 16, Iss. 5, pp. 991-991
Open Access | Times Cited: 8
Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in France
Marie Donzel, Maxime Bonjour, Jean‐Damien Combes, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101674-101674
Open Access | Times Cited: 18
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Hongwen Li, Wenting Song, Jiazhuo Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Genetic Landscape of Peripheral T-Cell Lymphoma
Vivian Hathuc, Friederike Kreisel
Life (2022) Vol. 12, Iss. 3, pp. 410-410
Open Access | Times Cited: 17
Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibody
Huixia He, Feifei Lei, Le Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114797-114797
Open Access | Times Cited: 6
A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry
Jie Jin, Xia Mao, Donghua Zhang
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 1
Modified SMILE (mSMILE) is active in the treatment of pediatric Epstein-Barr virus-associated natural killer/T-cell lymphoma: a single center experience, case series
Jian Li, Qizi Wu, Yongren Wang, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 7, pp. 1152-1160
Open Access | Times Cited: 1
Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease
Magda Zanelli, Paola Parente, Francesca Sanguedolce, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5458-5458
Open Access | Times Cited: 5
Cutaneous Intravascular Hematolymphoid Entities: A Review
Emily Hatheway Marshall, Bethany Brumbaugh, Allison Holt, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 679-679
Open Access
Extranodal Natural Killer/T-Cell Lymphoma Masquerading as Chronic Rhinosinusitis in a Native American Man
Kendra D. Marr, B. Collura, Rebecca Wig, et al.
Annals of Internal Medicine Clinical Cases (2024) Vol. 3, Iss. 4
Open Access
Mature T-cell and NK-cell neoplasms: Group 2
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song
Elsevier eBooks (2024), pp. 595-627
Closed Access
The impact of DNA tumor viruses in low-to-middle income countries (LMICS): A literature review
Bothwell Takaingofa Guzha, Allen Matubu, George Nyandoro, et al.
Tumour Virus Research (2024) Vol. 18, pp. 200289-200289
Open Access
From the midfacial destructive drama to the unfolding EBV story: a short history of EBV-positive NK-cell and T-cell lymphoproliferative diseases
C.S. Ng
Pathology (2024) Vol. 56, Iss. 6, pp. 773-785
Closed Access
Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood combined with hemophagocytic lymphohistiocytosis: a case report
Lixia Shi, Feifei Wang, Qi Wang, et al.
AME Case Reports (2024) Vol. 8, pp. 92-92
Open Access
Epigenetic regulation of Epstein–Barr virus: From bench to bedside
Xiao Gao, Hao‐Xu Yang, Shu Cheng, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 5
Open Access
Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review
Yongan Ni, Lei Li, Yuping Wang, et al.
The Turkish Journal of Pediatrics (2024) Vol. 66, Iss. 4, pp. 481-489
Open Access
Immune and microbial signatures in immunocompetent and immunocompromised patients with pneumonia
Yangqing Zhan, Jiemin Zhou, Shaoqiang Li, et al.
Research Square (Research Square) (2024)
Open Access
Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease
Sijia Yan, Xi Ming, Xiaojian Zhu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
One Case of Lymphoma with Skin Lesion as the First Symptom
爽爽 段
Journal of Clinical Personalized Medicine (2024) Vol. 03, Iss. 04, pp. 1483-1489
Open Access
Virus de Epstein-Barr: más que una mononucleosis infecciosa
Ana Isabel Toro-Montoya
Medicina y Laboratorio (2023) Vol. 27, Iss. 1, pp. 51-64
Open Access | Times Cited: 1
A Case of T/NK-Cell Post-Transplantation Lymphoproliferative Disease 7 Years after Heart Transplantation
Makiko Nakamura, Teruhiko Imamura, Kohji Takagi, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 2, pp. 38-38
Open Access | Times Cited: 1
Systemic EBV-positive T-cell lymphoma of childhood combined with hemophagocytic lymphohistocytosis: a case report
Lixia Shi, Feifei Wang, Qi Wang, et al.
Authorea (Authorea) (2023)
Open Access
Page 1

Scroll to top